Cebon, J Findlay, M Hargreaves, C Stockler, M Thompson, P Boyer, M Roberts, S Poon, A Scott, AM. Kalff, V Garas, G Dowling, A Crawford, D Ring, J Basser, R Strickland, A Macdonald, G Green, M Nowak, A Dickman, B Dhillon, H Gebski, V Australasian Gastro-Intestinal Trials Group (AGITG) AG0001H Investigators,
Collins, P Flather, M Lees, B Mister, R Proudler, AJ Stevenson, JC on behalf of the WHISP (Women’s Hormone Intervention Secondary Prevention Study) Pilot Study Investigators,
Cunningham, D Allum, WH Stenning, SP Thompson, JN Van de Velde, CJH Nicolson, M Scarffe, JH Lofts, FJ Falk, SJ Iveson, TJ Smith, DB Langley, RE Verma, M Weeden, S Chua, YJ for the MAGIC trial participants,
Debiec-Rychter, M Sciot, R Le Cesne, A Schlemmer, M Hohenberger, P van Oosterom, AT Blay, JY Leyvraz, S Stul, M Casali, PG Zalcberg, J Verweij, J Van Glabbeke, M Hagemeijer, A Judson, I on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group, EUROPEAN JOURNAL OF CANCER, 2006 DOI:10.1016/j.ejca.2006.01.030